» Articles » PMID: 30856190

The Related Factors of Sleep Benefit in Parkinson's Disease: A Systematic Review and Meta-analysis

Overview
Journal PLoS One
Date 2019 Mar 12
PMID 30856190
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Sleep benefit (SB) refers to the poorly understood phenomenon in Parkinson's disease (PD) in which patients wake up in the morning with improved motor function. Although previous studies have suggested that several related factors are associated with SB, this relationship remains controversial.

Objective: This systematic review and meta-analysis aimed to identify the possible related factors of SB in PD.

Methods: We searched PubMed, EMBASE and WanFang databases to collect eligible articles. We calculated pooled estimates of odds ratios (ORs) or the mean deviation (MD) with 95% confidence intervals.

Results: We found 3 related factors associated with SB: the duration of PD (MD 1.22, 95% CI: 0.21-2.23), sleep efficiency (MD -4.48,95% CI: -7.24- -2.44), and on-state MDS-UPDRS-Ⅲ total score (MD 3.05, 95% CI: 0.53-5.57).

Conclusion: PD patients with SB are more likely to have a long duration of PD, a low sleep efficiency and a high MDS-UPDRS-Ⅲ total score. Our work helps obtain a better understanding of sleep SB in PD and its underlying mechanisms. More studies need to be conducted to evaluate the associations between clinical factors in PD and the SB phenomenon.

Citing Articles

Circadian disruption and sleep disorders in neurodegeneration.

Shen Y, Lv Q, Xie W, Gong S, Zhuang S, Liu J Transl Neurodegener. 2023; 12(1):8.

PMID: 36782262 PMC: 9926748. DOI: 10.1186/s40035-023-00340-6.


Current Update on Clinically Relevant Sleep Issues in Parkinson's Disease: A Narrative Review.

Suzuki K J Parkinsons Dis. 2021; 11(3):971-992.

PMID: 33896849 PMC: 8461662. DOI: 10.3233/JPD-202425.


Adjuvant β-Lactam Therapy Combined with Vancomycin or Daptomycin for Methicillin-Resistant Staphylococcus aureus Bacteremia: a Systematic Review and Meta-analysis.

Wang C, Ye C, Liao L, Wang Z, Hu Y, Deng C Antimicrob Agents Chemother. 2020; 64(11).

PMID: 32839217 PMC: 7577142. DOI: 10.1128/AAC.01377-20.


Nutrition and Lifestyle Interventions for Managing Parkinson's Disease: A Narrative Review.

Lister T J Mov Disord. 2020; 13(2):97-104.

PMID: 32498495 PMC: 7280935. DOI: 10.14802/jmd.20006.


Correction: The related factors of sleep benefit in Parkinson's disease: A systematic review and meta-analysis.

Zhong R, Chen Q, Zhang X, Zhang X, Lin W PLoS One. 2019; 14(5):e0216524.

PMID: 31042758 PMC: 6493744. DOI: 10.1371/journal.pone.0216524.

References
1.
Schapira A, Chaudhuri K, Jenner P . Non-motor features of Parkinson disease. Nat Rev Neurosci. 2017; 18(8):509. DOI: 10.1038/nrn.2017.91. View

2.
Bateman D, Levett K, Marsden C . Sleep benefit in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1999; 67(3):384-5. PMC: 1736545. DOI: 10.1136/jnnp.67.3.384. View

3.
Iranzo de Riquer A, Bergareche A, Campos V . Sleep disorders in Parkinson disease. Neurologist. 2011; 17(6 Suppl 1):S38-42. DOI: 10.1097/NRL.0b013e31823966f8. View

4.
van Gilst M, Mierlo P, Bloem B, Overeem S . Quantitative Motor Performance and Sleep Benefit in Parkinson Disease. Sleep. 2015; 38(10):1567-73. PMC: 4576330. DOI: 10.5665/sleep.5048. View

5.
Lee W, Evans A, Williams D . Subjective perception of sleep benefit in Parkinson's disease: Valid or irrelevant?. Parkinsonism Relat Disord. 2017; 42:90-94. DOI: 10.1016/j.parkreldis.2017.06.026. View